Axonics Inc

Overview

Axonics Inc (Axonics), formerly Axonics Modulation Technologies Inc is a medical device company. It develops and commercializes implantable neuromodulation technology for the treatment of urinary and bowel dysfunction. The company's Sacral Neuromodulation System (SNM) is designed for treating of overactive bladder, fecal incontinence, and urinary retention. The Axonics r-SNM system comprises a temporary disposable external trial system and implantable components such as a miniaturized rechargeable implantable stimulator, a universal remote control and an intuitive clinician programmer which facilitates the lead placement procedure and programming, tined lead, and patient-friendly items including charging system optimized for reduced charge time with no heating. Axonics is headquartered in Irvine, California, the US.
Key Stats
Address
26 Technology Drive, Irvine, California
Headquarters

United States of America

Contact

1 949 3966322

Website
www.axonics.com
No of Employees

416

Industry

Medical Equipment

Ticker Symbol & Exchange​

AXNX [NASD]

Revenue (2020)

$112 m

710.4% (2020 vs 2019)
Net Income (2020)

$-55 m

31.2% (2020 vs 2019)
Net Profit Margin

-49 %

91.5% (2020 vs 2019)
Market Cap *

$3,592 m

EPS *

$-1.5

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Axonics IncMedtronic PlcBoston Scientific Corp
Key Information
Headquarters United States of America Ireland United States of America
Headquarter City Irvine DUBLIN MARLBOROUGH
Headquarter State/Province California - Massachusetts
No. of Employees 416 90,000 38,000
Entity Type Public Public Public

Products & Services

Axonics is a medical technology company. The key products of the company include the following:

Products
  • Rechargeable Sacral Neuromodulation System
Brands
  • Axonics
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Acquisitions/Mergers/Takeovers In February, the company acquired Contura and its product Bulkamid, a urethral bulking agent.
2021 Contracts/Agreements In March, the company and Micro Systems Technologies entered into a partnership to manufacture a…
2018 Regulatory Approval In January, Axonics secured a marketing approval from the Therapeutic Goods Administration, Australian Department of…
2018 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2017 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2012 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Axonics Women's Health Limited

Address

14 Took’s Court, London
United Kingdom

Telephone

44 20 74217400

Website

www.contura.com/

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
11 May 2021 Axonics Modulation Technologies Raises USD201.3 Million in Public Offering of Shares Equity Offering Axonics Inc
11 May 2021 Axonics Prices Upsized Public Offering of Shares for USD175 Million Equity Offering Axonics Inc
02 Mar 2021 Axonics Modulation Technologies to Raise USD3.3 Million in Public Offering of Shares Equity Offering Axonics Inc
25 Feb 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
07 May 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
19 Nov 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit